A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
To determine the dose or doses of PF-00547659 that will be the most effective to improve or halt the disease symptoms in patients with moderate to severe ulcerative colitis.
Inclusion Criteria:
Exclusion Criteria:
St Louis, Missouri 63108, United States
New York, New York 10021, United States
New York, New York 10065, United States
Chapel Hill, North Carolina 27599, United States
Nashville, Tennessee 37212-1610, United States
Hamilton, Ontario L8N 3Z5, Canada
Jerusalem, 91120, Israel
Catanzaro, 88100, Italy
Saint Petersburg, 196247, Russia